Apr 28, 2023

CCI Approves Acquisition of Textiles Dyes and Chemical Business of Hunstman International by Archroma

On February 09, 2023, CCI approved the acquisition of textiles dyes and chemical business of Hunstman International LLC., (‘Huntsman International’) by Archromab Operations S.a.r.l.,  (Archroma / Acquirer) (‘Proposed Combination 2’). [1]  Later Archroma Germany GmBH., (‘Archroma Germany’) also became a notifying party.

Trigger Documents

Equity and asset purchase agreement between Archroma and Huntsman International dated August 9, 2022.

Parties to Proposed Combination 2

Both Hunstman International and Archroma are engaged in the manufacturing and supply of chemicals and dyes for textile processing. The CCI took note of certain finer aspects of the business i.e., the processes involved.

Overlaps and Competitive Assessment

The CCI noted that Hunstman International and Archroma have horizonal overlaps in:

i.     Six sub-segments within the segment of Textile Chemicals; and

ii.    Four sub-segments within the segment of Textile Dyes.

In said context, the CCI observed that none of these overlaps would cause any potential competition concerns keeping in mind: (i) the combined market shares of Hunstman International and Archroma (ranged from 5% – 30% in these markets); and (ii) the presence of other players in these markets.

Lastly, the CCI in terms of vertical interface, noted that Hunstman International purchases certain amounts of Aluminum Chloride (‘AC’) from Archroma, but the latter’s market share for AC is less than 5% both in India, and globally.

Accordingly, the CCI approved Proposed Combination 2, holding that it was unlikely to have any AAEC in India.

[1] Combination Registration No. C-2022/09/970.




These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.